XWELL, Inc. Overview
Pro stress-test →XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The company is pivoting toward diversified wellness infrastructure targeting both airport and non-airport markets.
Strategic Profile
Pro stress-test →Strategic initiatives include rebranding to XWELL, expanding retail products and integrating services across brands to drive non-airport growth and scalability. XWELL highlights a technology and data component through HyperPointe, which it describes as part of the operational and technological core of its biosurveillance and digital healthcare infrastructure, with HyperPointe integrated into existing operations to maintain digital platform and AI capabilities. The company remains early-stage with significant financial challenges, operating at a loss while pursuing growth initiatives.
Competitive Landscape
Pro stress-test →Investors comparing XWEL often look at related companies in the same sector, including bioAffinity Tech (BIAF), Mainz Biomed NV (MYNZ), Advanced Biomed Inc. (ADVB), Check Cap (CHEK), and Ispecimen Inc. (ISPC). Direct competitors in traveler wellness services remain fragmented, with XWELL holding dominant positioning in airport spa and COVID-era testing infrastructure.
Industry Context
XWELL, Inc. operates in Traveler wellness services and health surveillance.
Key facts
Headquarters: New York, US · Revenue: $26.3M (TTM); $29.2M (FY2025) · Market cap: $10.4M